Queensland University of Technology (QUT)

Master of Diagnostic Genomics

Queensland University of Technology (QUT)

Type of institution: University/Higher Education Institution
Level: Postgraduate
CRICOS: 00213J

Genomics is a rapidly evolving field, critical to cutting-edge health care and personalised medicine. We offer the only Master of Diagnostic Genomics in Australasia. During this course, you will develop advanced knowledge and research skills that prepare you to meet the requirements for HGSA professional accreditation as a diagnostic genomics scientist. You may align your study with specific career goals by selecting speciality units in molecular genetics, cytogenetics, or biochemical genetics. During second year, you will build on this speciality or choose to complete elective units in cancer genomics, genetic epidemiology, or computational biology.

Structure

144 credit points.

Subjects

  • Diagnostic Genomics

Standard entry requirements

A completed recognised bachelor degree (or higher award) with a minimum Grade Point Average (GPA) score of 4.00 on QUT's 7 point scale completed.

Recognition

Graduates of this course will have satisfied the exam component of the Human Genetics Society of Australasia (HGSA). To be eligible for professional accreditation as a diagnostic genomic scientist, graduates must submit their testamur along with five case studies to HGSA. This course has been designed to ensure graduates are in a strong position to submit this material shortly after graduation.

Study information

CampusFeesEntryMid year intakeAttendance
Online Domestic: $39,300
International: $106,200
No
  • Full-time : 1.5 years
  • Part-time : 3 years
  • Online/Off-campus : 1.5 years

Further information

This course is delivered online and can be completed in full-time or part-time study mode.

Related courses

Browse more courses
Is the information on this page correct? Request update
Enquire about this course
You must agree before submitting.

Become a member

Already a member? LoginForgot password?

Join the conversation